Research
New Proton Beam Therapy Centre Opens in London
A new proton beam therapy centre offers new hope for patients with hard to treat and rare cancers
Read More
Simple blood test could revolutionise head and neck cancer diagnoses
The new Galleri trial launched by NHS England could be a real game changer for head and neck cancer
Read More
New immunotherapy drug approved in England
Patients undergoing treatment for head and neck cancer will now have access to immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.
Read More
COVID-19 Update
We are delighted to share details about the impact of COVID-19 on Oracle Cancer Trust
Read More
5th Annual Research Event
We were delighted to welcome over 50 supporters and friends to our 5th research reception in London
Read More
New Da Vinci Robotic Surgery HQ opens in Oxford
Oracle visited the offices of Intuitive recently at the launch of their new UK headquarters in Oxford.
Read More
Prof Chris Nutting on the HPV vaccination programme for boys
Prof Chris Nutting talks about the crucial work he has done to ensure that HPV vaccination is available to both boys and girls in the UK as part of the NHS vaccination programme.
Read More
Oracle funded research being reviewed for major international Cancer Research journal
Oracle project title: Sensitizing p53 mutant head and neck cancer to oncolytic virotherapy by targeting the endoplasmic reticulum (ER) stress response. Over the last 2 years, Oracle Cancer Trust has…
Read MoreResearch in Focus
Update on Oracle funded project ‘Taste Dysfunction Following Radiotherapy for Head and Neck Cancer’ Taste dysfunction is one of the most frequent complaints of patients undergoing radiotherapy for head and…
Read More